AstraZeneca's COVID-19 vaccine to be trialed at five U.S. military sites

Five Department of Defense installations will participate in the Phase III trial of a COVID-19 vaccine, the Pentagon announced Thursday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.